1. Home
  2. LNAI vs MOGU Comparison

LNAI vs MOGU Comparison

Compare LNAI & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNAI
  • MOGU
  • Stock Information
  • Founded
  • LNAI N/A
  • MOGU 2011
  • Country
  • LNAI United States
  • MOGU China
  • Employees
  • LNAI N/A
  • MOGU N/A
  • Industry
  • LNAI Biotechnology: Pharmaceutical Preparations
  • MOGU Business Services
  • Sector
  • LNAI Health Care
  • MOGU Consumer Discretionary
  • Exchange
  • LNAI Nasdaq
  • MOGU Nasdaq
  • Market Cap
  • LNAI 23.9M
  • MOGU 19.8M
  • IPO Year
  • LNAI N/A
  • MOGU 2018
  • Fundamental
  • Price
  • LNAI $1.25
  • MOGU $2.53
  • Analyst Decision
  • LNAI
  • MOGU
  • Analyst Count
  • LNAI 0
  • MOGU 0
  • Target Price
  • LNAI N/A
  • MOGU N/A
  • AVG Volume (30 Days)
  • LNAI 9.2M
  • MOGU 10.2K
  • Earning Date
  • LNAI 11-14-2025
  • MOGU 11-21-2025
  • Dividend Yield
  • LNAI N/A
  • MOGU N/A
  • EPS Growth
  • LNAI N/A
  • MOGU N/A
  • EPS
  • LNAI N/A
  • MOGU N/A
  • Revenue
  • LNAI N/A
  • MOGU $19,462,964.00
  • Revenue This Year
  • LNAI N/A
  • MOGU N/A
  • Revenue Next Year
  • LNAI N/A
  • MOGU N/A
  • P/E Ratio
  • LNAI N/A
  • MOGU N/A
  • Revenue Growth
  • LNAI N/A
  • MOGU N/A
  • 52 Week Low
  • LNAI $0.81
  • MOGU $1.83
  • 52 Week High
  • LNAI $21.00
  • MOGU $8.10
  • Technical
  • Relative Strength Index (RSI)
  • LNAI N/A
  • MOGU 39.67
  • Support Level
  • LNAI N/A
  • MOGU $2.54
  • Resistance Level
  • LNAI N/A
  • MOGU $2.65
  • Average True Range (ATR)
  • LNAI 0.00
  • MOGU 0.14
  • MACD
  • LNAI 0.00
  • MOGU -0.00
  • Stochastic Oscillator
  • LNAI 0.00
  • MOGU 9.09

About LNAI Lunai Bioworks Inc. Common Stock

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

About MOGU MOGU Inc.

MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.

Share on Social Networks: